Core Viewpoint - Walgreens Boots Alliance, Inc. is facing significant challenges, including declining stock prices and operational difficulties, despite some recent improvements in quarterly results [1][3][10]. Financial Performance - In Q3 2024, Walgreens Boots Alliance reported sales of $36,351 million, reflecting a 2.6% year-over-year growth, and an operating income of $111 million, a turnaround from an operating loss of $477 million in Q3 2023 [3][4]. - Diluted earnings per share increased from $0.14 in Q3 2023 to $0.40 in Q3 2024, marking a 186% year-over-year growth [3]. - Free cash flow improved from a negative $444 million to a positive $334 million in the same quarter [3]. Segment Analysis - The U.S. Retail Pharmacy segment generated $28,503 million in sales with a 2.3% year-over-year growth, but adjusted operating income declined 47.9% to $501 million [4][5]. - The International segment saw sales increase to $5,727 million, a 2.8% growth, but adjusted operating income fell 15.9% to $175 million [5][6]. - The U.S. Healthcare segment reported a 7.6% year-over-year sales growth to $2,125 million, but still faced an operating loss of $220 million [6]. Impairment and Balance Sheet - A significant non-cash goodwill impairment charge of $12.4 billion was recognized due to a downward revision in the long-term forecast from VillageMD management [7]. - Goodwill on the balance sheet decreased from $28,187 million to $15,821 million, indicating a substantial write-off [7]. - The company has limited cash reserves of $703 million, raising concerns about liquidity, especially with $1,506 million in short-term debt and $7,407 million in long-term debt [7][8]. Dividend Policy - Walgreens Boots Alliance cut its dividend to $0.25 per share, a nearly 50% reduction, losing its status as a dividend aristocrat [9]. - The current annual dividend of $1.00 results in a yield of 6.3%, but further cuts may be necessary depending on cash generation in the upcoming quarters [9]. Future Outlook - Management has lowered the adjusted EPS guidance for fiscal 2024 to a range of $2.80 to $2.95, reflecting ongoing challenges in the retail pharmacy business and a difficult consumer environment [10][11]. - Despite some signs of hope, the overall sentiment remains cautious, with the company needing to manage its turnaround effectively to regain profitability [13].

Key TakeawaysWalgreens Boots Alliance stock plummeted to a 27-year low on Thursday after the pharmacy chain and healthcare provider missed profit estimates and slashed its outlook amid weakening consumer demand.Walgreens shares started their long-term downtrend after toping out in August 2015, with the decline accelerating from July 2022 following a death cross, a bearish chart pattern that signals lower prices. Walgreens' share price may reclaim the $14 level near a 1997 price peak in the short-term due to ...

Walgreens Boots Alliance NASDAQ: WBA is a global leader in integrated healthcare, pharmacy, and retail. The company recently released its earnings report for the third quarter of 2024, raising questions about its ability to navigate a challenging market environment and achieve sustainable growth.Walgreens Boots Alliance TodayWBAWalgreens Boots Alliance$12.19 -3.47 (-22.16%) 52-Week Range$11.68▼$31.32Dividend Yield8.20%Price Target$23.07Add to WatchlistThe company’s expansive network of approximately 12,500 ...

Key TakeawaysThe S&P 500 edged 0.1% higher on Thursday, June 27, 2024, ahead of key inflation data set for release on Friday.Shares of server and data storage provider Super Micro Computer moved higher as the company aims to sustain its strong growth trajectory.Walgreens Boots Alliance shares tumbled after the pharmacy giant missed quarterly earnings estimates and announced it would close underperforming stores. Major U.S. equities indexes posted moderate gains on Thursday ahead of Friday's Personal Consump ...

FORM 10-Q (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) Delaware 47-1758322 108 Wilmot Road, Deerfield, Illinois 60015 ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended May 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...

Management continues to lower expectations.Shares of pharmacy Walgreens Boots Alliance (WBA -23.85%) fell as much as 25.4% in trading on Thursday after reporting fiscal third-quarter 2024 results. Shares are still down 24.7% at 3 p.m. ET.Weaker than expected resultsManagement said revenue was up 2.6% to $36.4 billion, and net income nearly tripled to $344 million, or $0.40 per share. The big change was earnings guidance for the full year being cut from a range of $3.20 to $3.35 down to a range of $2.80 to $ ...

Challenges in the retail environment and the pharmacy industry have led Walgreens Boots Alliance to consider closing as many as 25% of its U.S. retail stores.These Walgreens stores do not contribute to the firm’s adjusted operating income, and the company expects that a “significant portion” of these underperforming stores will be closed over the next three years, Walgreens Boots Alliance CEO Tim Wentworth said Thursday (June 27) during the company’s quarterly earnings call.For the remainder of those underp ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

HONG KONG, CHINA - 2024/06/21: In this photo illustration, the American pharmacy chain Walgreens ... [+] (NASDAQ: WBA) logo seen displayed on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesWalgreens recently reported its Q3’24 results (fiscal ends in August), with revenue exceeding but earnings falling short of our expectations. The company reported revenue of $ ...

Walgreens on Thursday said it could shutter up to a quarter of its more than 8,600 US locations amid plunging retail sales as inflation-battered shoppers cut back on spending.The struggling drug store chain, which closed 150 US locations last year, cut its profit forecast ahead of reporting its quarterly earnings — sending the company’s stock plummeting by nearly 25% in mid-day trading.Walgreens CEO Tim Wentworth, who took over the 123-year-old company in October, cited “persistent pressures on the US consu ...